| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.22 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |